Reality star Katie Thurston, 35, known from The Bachelorette, is using her public platform to raise awareness about breast cancer, openly sharing her journey with the disease. During a recent podcast conversation with actress Miranda McKeon, 24, Thurston reflected on the responsibility that comes with her visibility.
“In a weird way, I’m thankful I’m someone who has breast cancer because I have this massive platform for women whom I can educate that cancer does not happen 40 and above — it can happen at any time, and here’s how to be proactive,” Thurston said.
Thurston first announced her diagnosis in February 2025, revealing she had stage 3 triple-positive ductal carcinoma, a rare and aggressive form of breast cancer. Just one month later, she learned the cancer had metastasized to her liver, advancing her condition to stage 4.
Triple-positive breast cancer, characterized by estrogen receptors (ER), progesterone receptors (PR), and HER2 positivity, accounts for only 5–10% of breast cancer cases and typically requires a combination of chemotherapy, HER2-targeted therapy, and hormone therapy.
Despite the challenges, Thurston continues treatment, including chemotherapy, and shares the emotional and physical impact with her followers. She remains optimistic, reporting that her tumor is “still shrinking” and that her progress prompted her medical team to postpone a planned double mastectomy.
Thurston and McKeon are part of SurvivorNet’s Breast Cancer Dialogues series, which encourages women to share their experiences and feel supported throughout their journey. Both were diagnosed at young ages—Thurston at 34 and McKeon at 19.
McKeon, diagnosed with stage 3 hormone-positive breast cancer, underwent chemotherapy, a double mastectomy, reconstruction, and 25 rounds of radiation. She continues hormone therapy with Lupron, which suppresses estrogen production to prevent cancer growth.
“You’re almost like trained that cancer doesn’t happen until you’re like 40 and above, which is obviously not true,” Thurston said. Her comments echo a growing concern among experts: breast and other cancers are increasingly diagnosed in people under 50, with the most notable rise among those aged 20 to 29.
The American Cancer Society recommends annual mammograms starting at age 45 for women at average risk, while women aged 40–44 may begin screening at their discretion. Early detection can improve outcomes but may also lead to false positives and anxiety.
For those facing breast cancer surgery, experts emphasize that treatment is highly personalized. Decisions between lumpectomy and mastectomy depend on tumor size, location, genetic factors, and personal preference. For high-risk patients with BRCA mutations, preventive mastectomy may significantly reduce cancer risk.
Thurston’s current treatment includes Kisqali (ribociclib), Lupron (leuprolide), and Letrozole, targeting cancer growth through hormonal and targeted therapies. Though stage 4 breast cancer is not curable, ongoing research and a range of treatment options—including chemotherapy, hormonal therapy, targeted therapy, radiation, and clinical trials—offer hope for patients to live longer and maintain quality of life.
Thurston’s openness underscores the importance of awareness, proactive screening, and access to personalized care, offering hope to young women confronting a disease often associated with older age.
